APA (7th ed.) Citation

Cameli, P., Alonzi, V., d’Alessandro, M., Bergantini, L., Pordon, E., Guerrieri, M., . . . Bargagli, E. (2022). The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study. MDPI AG.

Chicago Style (17th ed.) Citation

Cameli, Paolo, Valerio Alonzi, Miriana d’Alessandro, Laura Bergantini, Elena Pordon, Marco Guerrieri, Rosa Metella Refini, Piersante Sestini, and Elena Bargagli. The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study. MDPI AG, 2022.

MLA (9th ed.) Citation

Cameli, Paolo, et al. The Effectiveness of Nintedanib in Patients with Idiopathic Pulmonary Fibrosis, Familial Pulmonary Fibrosis and Progressive Fibrosing Interstitial Lung Diseases: A Real-World Study. MDPI AG, 2022.